Virtual 2021 symposium | 11/9/21

Digital Innovations: Jumping from Concepts to the Clinic

11 September, 11:00 CEST

Chairperson(s): N. Bressler USA

Details

Digital Innovations: Jumping from Concepts to the Clinic

Chairperson(s): N. Bressler USA
Speakers:
Presentations:
Speakers and presentations:
N. Bressler USA
11:00 Welcome and Open
A. Loewenstein ISRAEL
11:05 Clinical endpoint collection outside of the office
P. Keane UK
11:15 Artificial intelligence: why hasn’t it jumped to the clinic yet?​
All Faculty
11:25 Panel discussion and Q&A
N. Bressler USA
11:40 Summary and close
 
11:45 End of Session
 

Maximizing Treatment Benefits for our Patients with Retinal Vascular Diseases

11 September, 11:00 CEST

Chairperson(s): J. Kitchens USA

Details

Maximizing Treatment Benefits for our Patients with Retinal Vascular Diseases

Chairperson(s): J. Kitchens USA
Speakers:
Presentations:
Speakers and presentations:
V. Chaudhary CANADA 
11:00 Maximizing vision outcomes in DME: is baseline VA only one piece of the puzzle?
J. Garweg SWITZERLAND 
11:10 Durability that lasts: proactive, extended dosing in retinal vascular disease
A. Chang AUSTRALIA 
11:20 Aflibercept in the real-world: what’s the bigger picture?
T. Langmann GERMANY 
11:27 Understanding the target: what are we aiming for?
 
11:35 End of Session
 

Evolution in Surgical Techniques – The Modern VR Procedure

11 September, 11:00 CEST

Chairperson(s): R. Tadayoni FRANCE

Details

Evolution in Surgical Techniques - The Modern VR Procedure

Chairperson(s): R. Tadayoni FRANCE
Speakers:
Presentations:
Speakers and presentations:
R. Tadayoni FRANCE
11:00 Welcome and introduction to nAMD​
D. Chow CANADA
11:01 The shovel and cut technique: management of complex diabetic retinopathy in 25G surgery
S. Rizzo ITALY
11:15 Speed and stability: rethinking 27G surgery
R. Tadayoni FRANCE
11:29  Panel Discussion
B. Delas SPAIN
11:29 Panel Discussion
F. Barca ITALY
11:29 Panel Discussion
T. Ivonova UK
11:29 Panel Discussion
 
11:35 End of Session
 

Best-informed Decision Making – Latest Innovations in Retinal Imaging and Surgical Visualization

11 September, 11:00 CEST

Chairperson(s): J.F Korobelnik FRANCE

Details

Best-informed Decision Making – Latest Innovations in Retinal Imaging and Surgical Visualization

Chairperson(s): J.F. Korobelnik FRANCE
Speakers:
Presentations:
Speakers and presentations:
J.F. Korobelnik FRANCE
11:00 Advancements in multi-modal imaging
R. Tadayoni FRANCE
11:07 Visualization from multi-modal imaging in the clinic to 3D in the OR
L-O Hattenbach GERMANY
11:19 Changing paradigms - real-time OCT guided approaches to vitreoretinal surgery
All Faculty
11:26 Panel Discussion
 
11:45 End of Session
 

Managing Patients with Diabetic Macular Edema Through the Pandemic and Beyond: Discussing Ongoing Strategies

11 September, 14:00 CEST

Chairperson(s): R. Tadayoni FRANCE

Details

Managing Patients with Diabetic Macular Edema Through the Pandemic and Beyond: Discussing Ongoing Strategies

Chairperson(s): R. Tadayoni FRANCE
Speakers:
Presentations:
Speakers and presentations:
R. Tadayoni FRANCE
11:00 Welcome and introduction
R. Tadayoni FRANCE
11:03 Managing DME: understanding the challenges​ | DME and COVID-19: what have we learnt?​ | What will last beyond the pandemic: ongoing strategies ​
S. Sivaprasad UK
11:03 Managing DME: understanding the challenges​ | DME and COVID-19: what have we learnt?​ | What will last beyond the pandemic: ongoing strategies ​
P. Schlottmann ARGENTINA
11:03 Managing DME: understanding the challenges​ | DME and COVID-19: what have we learnt?​ | What will last beyond the pandemic: ongoing strategies ​
All Faculty
14:27 Panel discussion: Q&A​
R. Tadayoni FRANCE
14:42Summary and close​
 
End of Session
 

Flexibility and Long-term Predictability: Unlocking the Potential of Q16 Dosing for your Patients

11 September, 14:00 CEST

Chairperson(s): D. Wong CANADA

Details

Flexibility and Long-term Predictability: Unlocking the Potential of Q16 Dosing for your Patients

Chairperson(s): D. Wong CANADA
Speakers:
Presentations:
Speakers and presentations:
N. Holekamp USA
14:00 Fluid in nAMD: a pragmatic approach
J. Zarranz-Ventura SPAIN
14:10 Maintaining function with flexible treatment intervals up to Q16
TBC
14:20 Not just a case study: real-world outcomes with aflibercept
M. Stewart USA
14:28 Making sense of molecular properties
 
End of Session
 

Amgen: Spotlight on Real-world Considerations for Biosimilars in Ophthalmology

11 September, 14:00 CEST

Chairperson(s): J. Franklin USA

Details

Amgen: Spotlight on Real-world Considerations for Biosimilars in Ophthalmology

Chairperson(s): J. Franklin USA
Speakers:
Presentations:
Speakers and presentations:
J. Franklin USA
14:00 Spotlight on real-world considerations for biosimilars in ophthalmology
D. Sarraf USA
14:00 Spotlight on real-world considerations for biosimilars in ophthalmology
J. Franklin USA
14:30 Q&A
D. Sarraf USA
14:30 Q&A
 
14:45 End of Session
 

AMD Fluid Resolution: Optimizing Real-world Outcomes in nAMD Treatment

11 September, 18:15 CEST

Chairperson(s): F.G. Holz GERMANY

Details

AMD Fluid Resolution: Optimizing Real-world Outcomes in nAMD Treatment

Chairperson(s): F.G. Holz GERMANY
Speakers:
Presentations:
Speakers and presentations:
F.G. Holz GERMANY
18:15 Welcome, ARS and review of EURETINA AMD clinical trends survey data
S. Wolf SWITZERLAND
18:20 Best practices for diagnosing & monitoring AMD
N. Eter GERMANY
18:30 nAMD patient selection and outcome goals for Anti-VEGF treatment
R. Tadayoni FRANCE
18:40 nAMD treatment protocols and therapy decisions
R. Singh USA
18:50 Real-world experience with new Anti-VEGFs
F.G. Holz GERMANY
19:00 Final ARS & panel discussion
 
19:15 End of Session
 

Secretariat Address
European Society of Retina Specialists
Ground Floor, The Apex Building 
Blackthorn Road
Sandyford Business Park
Co Dublin, D18 H6K2

Phone:+353 1 2100092
Email: [email protected]

EURETINA 2022 Hamburg

Opportunities

Memberships

Forum

About

Privacy Policy

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 

Follow us

© EURETINA 2021 All rights reserved